Opko Health, Inc.
Insider CIK 944809 · SVON 10% owner · WGS 10% owner · VBIV 10% owner · OTCQB:SRNE 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| WGS GeneDx Holdings Corp. | S Sale | 2024-08-19 | 2024-08-19 | 50,000 | $34.49 | $1.72M | 2,646,972 | SEC↗ |
| WGS GeneDx Holdings Corp. | S Sale | 2024-08-16 | 2024-08-19 | 50,000 | $34.30 | $1.71M | 2,696,972 | SEC↗ |
| WGS GeneDx Holdings Corp. | S Sale | 2024-08-15 | 2024-08-19 | 39,824 | $33.08 | $1.32M | 2,746,972 | SEC↗ |
| WGS GeneDx Holdings Corp. | S Sale | 2024-08-13 | 2024-08-14 | 24,987 | $34.76 | $868.5K | 2,786,796 | SEC↗ |
| WGS GeneDx Holdings Corp. | S Sale | 2024-08-12 | 2024-08-14 | 59,787 | $33.95 | $2.03M | 2,811,783 | SEC↗ |
| WGS GeneDx Holdings Corp. | S Sale | 2024-08-08 | 2024-08-08 | 100,000 | $31.82 | $3.18M | 2,871,570 | SEC↗ |
| WGS GeneDx Holdings Corp. | S Sale | 2024-08-06 | 2024-08-08 | 12,994 | $29.35 | $381.4K | 2,971,570 | SEC↗ |
| WGS GeneDx Holdings Corp. | S Sale | 2024-07-31 | 2024-08-02 | 88,839 | $33.50 | $2.98M | 2,984,564 | SEC↗ |
| WGS GeneDx Holdings Corp. | S Sale | 2024-07-29 | 2024-07-31 | 50,000 | $33.86 | $1.69M | 3,073,403 | SEC↗ |
| WGS GeneDx Holdings Corp. | S Sale | 2024-07-26 | 2024-07-26 | 60,000 | $33.85 | $2.03M | 3,123,403 | SEC↗ |
| WGS GeneDx Holdings Corp. | S Sale | 2024-07-24 | 2024-07-26 | 75,000 | $33.72 | $2.53M | 3,183,403 | SEC↗ |
| WGS GeneDx Holdings Corp. | S Sale | 2024-07-23 | 2024-07-23 | 75,000 | $33.46 | $2.51M | 3,258,403 | SEC↗ |
| WGS GeneDx Holdings Corp. | S Sale | 2024-07-22 | 2024-07-23 | 50,000 | $32.61 | $1.63M | 3,333,403 | SEC↗ |
| WGS GeneDx Holdings Corp. | S Sale | 2024-07-19 | 2024-07-23 | 25,000 | $32.29 | $807.3K | 3,383,403 | SEC↗ |
| WGS GeneDx Holdings Corp. | S Sale | 2024-07-17 | 2024-07-19 | 25,000 | $32.93 | $823.3K | 3,408,403 | SEC↗ |
| WGS GeneDx Holdings Corp. | S Sale | 2024-07-05 | 2024-07-09 | 36,118 | $28.24 | $1.02M | 3,433,403 | SEC↗ |
| WGS GeneDx Holdings Corp. | S Sale | 2024-07-03 | 2024-07-03 | 14,082 | $28.23 | $397.5K | 3,469,521 | SEC↗ |
| WGS GeneDx Holdings Corp. | S Sale | 2024-07-02 | 2024-07-03 | 25,000 | $29.12 | $728.0K | 3,483,603 | SEC↗ |
| WGS GeneDx Holdings Corp. | S Sale | 2024-07-01 | 2024-07-03 | 50,000 | $26.63 | $1.33M | 3,508,603 | SEC↗ |
| WGS GeneDx Holdings Corp. | A Award | 2023-04-11 | 2023-04-13 | 23,148,148 | — | $0 | 117,433,862 | SEC↗ |
| WGS GeneDx Holdings Corp. | P Buy | 2023-01-26 | 2023-01-31 | 14,285,714 | $0.35 | $5.00M | 94,285,714 | SEC↗ |
| SVOND Sevion Therapeutics, Inc. | A Award | 2017-12-19 | 2017-12-21 | 495,126 | — | $0 | 1,289,818 | SEC↗ |
| VBIV VBI Vaccines Inc/BC | P Buy | 2017-10-30 | 2017-11-01 | 655,738 | $3.05 | $2.00M | 6,678,752 | SEC↗ |
| SVON Sevion Therapeutics, Inc. | C Conversion deriv | 2017-09-19 | 2017-11-07 | 66,667 | — | $0 | 0 | SEC↗ |
| SVON Sevion Therapeutics, Inc. | C Conversion | 2017-09-19 | 2017-11-07 | 1,250,006 | — | $0 | 15,893,844 | SEC↗ |
| SVON Sevion Therapeutics, Inc. | C Conversion deriv | 2017-08-10 | 2017-08-14 | 0 | — | $0 | 0 | SEC↗ |
| SVON Sevion Therapeutics, Inc. | C Conversion deriv | 2017-08-10 | 2017-08-14 | 0 | — | $0 | 0 | SEC↗ |
| SVON Sevion Therapeutics, Inc. | C Conversion | 2017-08-10 | 2017-08-14 | 1,563,123 | $0.10 | $156.3K | 12,080,139 | SEC↗ |
| SVON Sevion Therapeutics, Inc. | C Conversion | 2017-08-10 | 2017-08-14 | 2,563,699 | $0.10 | $256.4K | 14,643,838 | SEC↗ |
| SRNE Sorrento Therapeutics, Inc | S Sale | 2013-11-26 | 2013-11-27 | 8,714 | $8.54 | $74.4K | 2,153,045 | SEC↗ |
| SRNE Sorrento Therapeutics, Inc | S Sale | 2013-11-25 | 2013-11-27 | 12,100 | $8.54 | $103.3K | 2,161,759 | SEC↗ |
| SRNE Sorrento Therapeutics, Inc | S Sale | 2013-11-22 | 2013-11-25 | 8,471 | $8.50 | $72.0K | 2,173,859 | SEC↗ |
| SRNE Sorrento Therapeutics, Inc | S Sale | 2013-11-21 | 2013-11-22 | 4,269 | $8.53 | $36.4K | 2,182,330 | SEC↗ |
| SRNE Sorrento Therapeutics, Inc | S Sale | 2013-11-20 | 2013-11-21 | 16,962 | $8.75 | $148.4K | 2,186,599 | SEC↗ |
| SRNE Sorrento Therapeutics, Inc | S Sale | 2013-11-19 | 2013-11-21 | 100 | $8.75 | $875 | 2,203,561 | SEC↗ |
| SRNE Sorrento Therapeutics, Inc | S Sale | 2013-11-15 | 2013-11-18 | 2,710 | $8.75 | $23.7K | 2,203,661 | SEC↗ |
| SRNE Sorrento Therapeutics, Inc | S Sale | 2013-11-14 | 2013-11-15 | 1,900 | $8.75 | $16.6K | 2,206,371 | SEC↗ |
| SRNE Sorrento Therapeutics, Inc | S Sale | 2013-11-13 | 2013-11-14 | 13,457 | $8.75 | $117.7K | 2,208,271 | SEC↗ |
| SRNE Sorrento Therapeutics, Inc | S Sale | 2013-11-08 | 2013-11-12 | 2,000 | $8.75 | $17.5K | 2,221,728 | SEC↗ |
| SRNE Sorrento Therapeutics, Inc | S Sale | 2013-11-07 | 2013-11-08 | 5,418 | $9.07 | $49.1K | 2,223,728 | SEC↗ |
| SRNE Sorrento Therapeutics, Inc | S Sale | 2013-11-06 | 2013-11-08 | 114,962 | $9.03 | $1.04M | 2,229,146 | SEC↗ |
| OTCQB:SRNE Sorrento Therapeutics, Inc | S Sale | 2013-09-04 | 2013-09-04 | 55 | $8.01 | $441 | 2,344,108 | SEC↗ |
| OTCQB:SRNE Sorrento Therapeutics, Inc | S Sale | 2013-09-04 | 2013-09-04 | 9,300 | $7.75 | $72.1K | 2,344,163 | SEC↗ |
| OTCQB:SRNE Sorrento Therapeutics, Inc | S Sale | 2013-08-29 | 2013-08-30 | 100 | $7.75 | $775 | 2,353,463 | SEC↗ |
| OTCQB:SRNE Sorrento Therapeutics, Inc | S Sale | 2013-08-28 | 2013-08-28 | 641 | $7.75 | $5.0K | 2,353,563 | SEC↗ |
| OTCQB:SRNE Sorrento Therapeutics, Inc | S Sale | 2013-08-26 | 2013-08-28 | 1,615 | $8.00 | $12.9K | 2,354,204 | SEC↗ |
| OTCQB:SRNE Sorrento Therapeutics, Inc | S Sale | 2013-08-20 | 2013-08-21 | 1,560 | $7.78 | $12.1K | 2,355,819 | SEC↗ |
| OTCQB:SRNE Sorrento Therapeutics, Inc | S Sale | 2013-08-14 | 2013-08-16 | 2,900 | $8.95 | $26.0K | 2,357,379 | SEC↗ |
| OTCQB:SRNE Sorrento Therapeutics, Inc | S Sale | 2013-08-07 | 2013-08-15 | 331 | $8.50 | $2.8K | 2,360,279 | SEC↗ |